Schadt Eric
President & Chief R&D Officer at WGS
- Sold, on record
- $412k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Apr 28, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- WGSGeneDx Holdings Corp.President & Chief R&D Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale WGSUnusualOct 25, 2021 2021
Sold 33,332 shares at $7.54 ($251k)
Schadt Eric, Chief Executive Officer
Sold 42.3% of holdings ($594k position)45,480 shares leftFirst sale on recordFiling
- 2 Form 4 sale WGSPlan not statedJan 28, 2022 +95 days
Sold 29,100 shares at $2.84 ($83k)
Schadt Eric, Chief Executive Officer
Sold 22.5% of holdings ($368k position)100,467 shares leftFiling
- 3 Form 4 sale WGSPlan not statedApr 28, 2022 +90 days
Sold 35,899 shares at $2.18 ($78k)
Schadt Eric, President & Chief R&D Officer
Sold 20% of holdings ($391k position)143,380 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2022 | May 2, 2022 | WGS | President & Chief R&D Officer | Form 4 sale | 35,899 | $78k | 20.0% | Plan not stated | SEC |
| Jan 28, 2022 | Feb 2, 2022 | WGS | Chief Executive Officer | Form 4 sale | 29,100 | $83k | 22.5% | Plan not stated | SEC |
| Oct 25, 2021 | Nov 2, 2021 | WGS | Chief Executive Officer | Form 4 sale | 33,332 | $251k | 42.3% | Unusual | SEC |